← Russell 3000 cross-section

ALAB Astera Labs, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-05, not restated
Technology

Scale

Market cap
$52.3bn
Revenue TTM
$1.2bn
Net income TTM
$370m
Free cash flow
$277m
Composite score
39.6
Sector rank
#229

Valuation

P / E
141.6
EV / EBITDA
EV / sales
42.5
FCF yield
0.53%
Earnings yield vs 10-yr
-4.02pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
30.7%
EBITDA margin
ROE
21.4%
ROIC
57.8%
Revenue growth
98.5%

Insider activity, last 90 days

Net open-market
$-163.14m
Buyers
0
Sellers
7

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Our revenue grew from $34.8 million in 2021, $79.9 million in 2022, $115.8 million in 2023, and $396.3 million in 2024, to $852.5 million in 2025. Our revenue was $700.8 million for the six months ended June 30, 2026, driven by a sizable increase in demand for our products. Summary of Financial Highlights Our revenue was $392.4 million for the three months ended June 30, 2026, c ompared to $191.9 million for the same period in 2025, representing an increase of 104% year over year. Our revenue was $700.8 million for the six months ended June 30, 2026 c ompared to $351.4 million for the same period in 2025, representing an increase of 99% year over year. …Astera Labs, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-05

Read the full passage →